/
Other
7.4KDiseases↗
10.9KPipeline Programs↗
16.2KActive Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
94,880
clinical trials
Completed56,828 · 60%
Unknown status11,753 · 12%
Recruiting8,666 · 9%
Terminated6,394 · 7%
Not yet recruiting4,049 · 4%
Withdrawn3,094 · 3%
Other4,096 · 4%
Landscape
Diseases
TED
Most programs0
Programs
4,000
Trials
26
Recruiting
AIN
Most trials0
Programs
2,449
Trials
24
Recruiting
MPA
Highest activity0
Programs
2,322
Trials
21
Recruiting
ILD
0 programs1194 trials
Tics
11 program1182 trialsApproved
CLE
0 programs1010 trials
TIA
0 programs879 trials
SCLC
10 programs823 trialsPhase 1
NSCLC
50 programs711 trialsPhase 3
Prostate CA
0 programs647 trials
Pancreatic
10 programs558 trials
Colorectal
10 programs546 trials
Aging
20 programs527 trials
POI
0 programs508 trials
SLE
0 programs498 trials
Kidney
30 programs477 trialsApproved
Gastric
10 programs469 trialsPreclinical
ACL
20 programs447 trials
Ovarian
30 programs446 trialsPhase 3
Imaging
0 programs438 trials
ISS
0 programs435 trials
PD-1
0 programs434 trials
Adjuvant Therapy
0 programs427 trials
Prospective
0 programs426 trials
OSA
0 programs425 trials
Women
50 programs424 trialsApproved
Nivolumab
0 programs415 trials
Myeloid
10 programs413 trialsPhase 2
Bevacizumab
0 programs413 trials
Antibody
10 programs412 trialsApproved
Showing top 30 diseases by activity. 7363 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)